TEHILA POTESKY: Open Payments
NPI 1891355459 · OLNEY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$121 in 6 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $140 · 2025 $121
Food & beverage: $121
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $55 |
| Novo Nordisk Inc | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
Products named: VRAYLAR, XIFAXAN, ZORYVE.
Industry payments across MD — which companies pay providers there.
